文献速递妇产影像介入CT

直线与弯曲虚拟棒空间分割放疗用于宫颈癌近距离治疗的临床前剂量学比较与质量保证

Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy-results from preclinical in-silico dose comparison and quality assurance.
PubMed 文献 · Br J Radiol · 2026-01-01

本研究基于10例局部晚期宫颈癌患者的CT数据集,在体素内比较直线与弯曲虚拟棒空间分割放疗计划的剂量学差异。两种配置靶区覆盖相当(D90无显著差异),危及器官D2cc均满足约束,gamma通过率在2%/2mm标准下大于90%。结论认为两种虚拟棒配置均可行,但需进一步临床验证。

要点

  • 直线与弯曲虚拟棒SFRT计划的HRCTV D90无统计学显著差异,靶区覆盖可比。
  • 膀胱、直肠、乙状结肠和肠管D2cc在两种计划中均不超过各自约束值。
  • 2%/2mm标准下gamma通过率均大于90%,计划交付质量保证可行。
英文原文(摘要)· 点击展开

OBJECTIVES: To compare virtual straight and bending rods Spatially Fractionated Radiation Therapy (SFRT) for cervical cancer brachytherapy delivery.

METHODS: CT scan datasets from 10 patients with locally advanced cervical cancer who received brachytherapy were included. For each patient, 2 distinct plans were generated: one using straight virtual rods and the other using bending virtual rods. The total prescribed dose was 30 Gy in 5 fractions. All plans were created with 10XFFF beam. Dosimetric parameters, including D90, V100%, V150%, and V200% for high-risk clinical target volume (HRCTV), were evaluated. Additionally, dose constraints for OARs (bladder, rectum, sigmoid, and bowel D2cc) were compared. Plan delivery quality assurance was performed using the Mobius verification phantom, and gamma passing rate was analyzed.

RESULTS: Comparable CTV coverage was observed between the 2 configurations. D90 values showing no statistically significant difference (P > .05). In both plans, the D2cc of bladder, rectum, sigmoid, and bowel were observed to be ≤23.75 Gy, ≤17.00 Gy, ≤19.50 Gy, and ≤17.00 Gy, respectively. The average hotspot in HRCTV was evaluated at 18.4% (±10.4) and 20.8% (±7.8) for V200%, respectively. The gamma passing rate was found to be greater than 90% for the 2%/2 mm criteria.

CONCLUSIONS: This in-silico study concludes that both virtual rod configurations provide comparable target coverage while effectively minimizing OAR exposure. Further clinical validation is recommended to confirm these findings.

ADVANCES IN KNOWLEDGE: This study demonstrates the feasibility of SFRT and the potential for future testing in patients who are unable to undergo brachytherapy.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Shinde P, Ak A, Agarwal P, et al. Spatially fractionated radiotherapy using straight and bending virtual rods as an alternative for cervical cancer brachytherapy-results from preclinical in-silico dose comparison and quality assurance. Br J Radiol. 2026. PMID: 42179164. doi:10.1093/bjr/tqag075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。